Literature DB >> 9481010

Proteolysis associated with insulin resistance in cystic fibrosis.

D S Hardin1, A LeBlanc, S Lukenbaugh, L Para, D K Seilheimer.   

Abstract

OBJECTIVE: We hypothesized that patients with cystic fibrosis (CF) have higher rates of protein breakdown than normal volunteers and that the infusion of insulin would result in less suppression of proteolysis. Methods. Using [1-C]leucine and a three-step hyperinsulinemic euglycemic clamp, we measured rates of leucine appearance in 29 adult CF patients and 18 matched-control volunteers. The CF patients were characterized by oral glucose tolerance testing and clinical status scoring.
RESULTS: The CF patients had significantly increased proteolysis when compared with that of controls (CF, 123 +/- 28 micromol/kg/h; controls, 71 +/- 15 micromol/kg/h) and rates of proteolysis were significantly different between CF patients with impaired glucose tolerance and diabetes and those CF patients with normal glucose tolerance. Suppression of proteolysis by insulin was less in all CF subgroups than in the controls at peripheral insulin levels of 16 and 29 microU/mL. At peripheral insulin levels of 100 microU/mL, there was no difference in insulin suppression of proteolysis between CF patients and controls. Importantly, basal rates of proteolysis had an inverse relationship with clinical status in CF patients (r = -.76).
CONCLUSIONS: Our findings indicate that proteolysis is higher in adult CF patients than in controls and that CF patients exhibit resistance to the anabolic effects of insulin on proteolysis. Most significantly, our findings indicate that basal rates of proteolysis inversely correlate with clinical status in CF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481010     DOI: 10.1542/peds.101.3.433

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

Review 1.  Routine screening for cystic fibrosis-related diabetes.

Authors:  Daniel Peckham
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

2.  Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients.

Authors:  Jamie L Wooldridge; Rhonda D Szczesniak; Matthew C Fenchel; Deborah A Elder
Journal:  J Cyst Fibros       Date:  2015-03-06       Impact factor: 5.482

3.  Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Yvette C Luiking; Nicolaas E P Deutz
Journal:  J Pediatr       Date:  2013-02-15       Impact factor: 4.406

4.  Normal bone mineral density in cystic fibrosis.

Authors:  D S Hardin; R Arumugam; D K Seilheimer; A LeBlanc; K J Ellis
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

5.  A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis.

Authors:  Michael S Stalvey; Ran D Anbar; Michael W Konstan; Joan R Jacobs; Bert Bakker; Barbara Lippe; David E Geller
Journal:  Pediatr Pulmonol       Date:  2011-09-08

6.  Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Authors:  Antoinette Moran; Penelope Pekow; Patricia Grover; Martha Zorn; Bonnie Slovis; Joseph Pilewski; Elizabeth Tullis; Theodore G Liou; Holley Allen
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152

Review 7.  Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Authors:  Antoinette Moran; Dorothy Becker; Samuel J Casella; Peter A Gottlieb; M Sue Kirkman; Bruce C Marshall; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

Review 8.  Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene.

Authors:  Wahju Aniwidyaningsih; Raphaëlle Varraso; Noel Cano; Christophe Pison
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-07       Impact factor: 4.294

Review 9.  Role of specific dietary amino acids in clinical conditions.

Authors:  Renate Jonker; Mariëlle P K J Engelen; Nicolaas E P Deutz
Journal:  Br J Nutr       Date:  2012-08       Impact factor: 3.718

10.  Glargine versus NPH insulin in cystic fibrosis related diabetes.

Authors:  Patricia Grover; William Thomas; Antoinette Moran
Journal:  J Cyst Fibros       Date:  2007-08-09       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.